Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue
Open Access
- 1 April 2004
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (4) , 1716-1718
- https://doi.org/10.1128/jcm.42.4.1716-1718.2004
Abstract
An international collaborative study was performed in order to propose quality control limits for voriconazole disk diffusion tests on Mueller-Hinton agar with 2% glucose and 0.5 μg of methylene blue per ml. The supplement may be added to the agar before autoclaving, or Mueller-Hinton agar plates may be flooded with a glucose-methylene blue solution. Replicate tests on both types of agar plates with 1-μg voriconazole disks generated data to propose zone size limits for tests of Candida parapsilosis ATCC 22019 (28 to 37 mm), Candida albicans ATCC 90028 (31 to 42 mm), and Candida krusei ATCC 6258 (16 to 25 mm). Candida tropicalis ATCC 750 was not useful for this purpose.Keywords
This publication has 9 references indexed in Scilit:
- Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene BlueJournal of Clinical Microbiology, 2003
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001Journal of Clinical Microbiology, 2003
- Voriconazole: A New Triazole Antifungal AgentAnnals of Pharmacotherapy, 2003
- Voriconazole: A New Triazole Antifungal AgentClinical Infectious Diseases, 2003
- Precision and Accuracy of Fluconazole Susceptibility Testing by Broth Microdilution, Etest, and Disk Diffusion MethodsAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida sppAntimicrobial Agents and Chemotherapy, 2002
- Voriconazole -- better chances for patients with invasive mycoses.2002
- In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literatureMycopathologia, 2001